Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Paratek Pharmaceuticals I...

    NASDAQ: PRTK · Real-Time Price · USD
    2.23
    0.04 (1.83%)
    At close: Sep 20, 2023, 10:00 PM

    Paratek Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 150.79M 120.95M
    Cost of Revenue
    		 23.06M 21.54M
    Gross Profit
    		 127.73M 99.42M
    Operating Income
    		 -46.21M -41.13M
    Interest Income
    		 752K 66K
    Pretax Income
    		 -63.51M -58.48M
    Net Income
    		 -63.57M -59.08M
    Selling & General & Admin
    		 145.6M 119.4M
    Research & Development
    		 37.82M 30.35M
    Other Expenses
    		 -9.48M -9.21M
    Operating Expenses
    		 173.94M 140.55M
    Interest Expense
    		 18.12M 17.41M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 197M 162.08M
    Income Tax Expense
    		 57K 600K
    Shares Outstanding (Basic)
    		 54.39M 48.42M
    Shares Outstanding (Diluted)
    		 54.39M 48.42M
    EPS (Basic)
    		 -1.17 -1.22
    EPS (Diluted)
    		 -1.17 -1.22
    EBITDA
    		 -44.9M -40.69M
    EBIT
    		 -45.39M -41.08M
    Depreciation & Amortization
    		 1.31M 445K

    Add to Watchlist